BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 11495981)

  • 1. A survey of heterobasidiomycetous yeasts for the presence of the genes homologous to virulence factors of Filobasidiella neoformans, CNLAC1 and CAP59.
    Petter R; Kang BS; Boekhout T; Davis BJ; Kwon-Chung KJ
    Microbiology (Reading); 2001 Aug; 147(Pt 8):2029-2036. PubMed ID: 11495981
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of the laccase gene CNLAC1, on virulence of Cryptococcus neoformans.
    Salas SD; Bennett JE; Kwon-Chung KJ; Perfect JR; Williamson PR
    J Exp Med; 1996 Aug; 184(2):377-86. PubMed ID: 8760791
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complementation of a capsule-deficient mutation of Cryptococcus neoformans restores its virulence.
    Chang YC; Kwon-Chung KJ
    Mol Cell Biol; 1994 Jul; 14(7):4912-9. PubMed ID: 8007987
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparisons of the laccase gene among serotypes and melanin-deficient variants of Cryptococcus neoformans.
    Tanaka E; Ito-Kuwa S; Nakamura K; Aoki S; Vidotto V; Ito M
    Microbiol Immunol; 2005; 49(3):209-17. PubMed ID: 15781994
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rapid direct identification of Cryptococcus neoformans from pigeon droppings by nested PCR using CNLAC1 gene.
    Chae HS; Park GN; Kim SH; Jo HJ; Kim JT; Jeoung HY; An DJ; Kim NH; Shin BW; Kang YI; Chang KS
    Poult Sci; 2012 Aug; 91(8):1983-9. PubMed ID: 22802194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CNLAC1 is required for extrapulmonary dissemination of Cryptococcus neoformans but not pulmonary persistence.
    Noverr MC; Williamson PR; Fajardo RS; Huffnagle GB
    Infect Immun; 2004 Mar; 72(3):1693-9. PubMed ID: 14977977
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The yeast Cryptococcus neoformans uses 'mammalian' enhancer sites in the regulation of the virulence gene, CNLAC1.
    Zhang S; Varma A; Williamson PR
    Gene; 1999 Feb; 227(2):231-40. PubMed ID: 10023069
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biochemical and molecular characterization of the diphenol oxidase of Cryptococcus neoformans: identification as a laccase.
    Williamson PR
    J Bacteriol; 1994 Feb; 176(3):656-64. PubMed ID: 8300520
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microreview: capsule-associated genes of Cryptococcus neoformans.
    Okabayashi K; Hasegawa A; Watanabe T
    Mycopathologia; 2007 Jan; 163(1):1-8. PubMed ID: 17216326
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Further analysis of the CAP59 locus of Cryptococcus neoformans: structure defined by forced expression and description of a new ribosomal protein-encoding gene.
    Chang YC; Wickes BL; Kwon-Chung KJ
    Gene; 1995 Dec; 167(1-2):179-83. PubMed ID: 8566774
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular analysis of CAP59 gene sequences from five serotypes of Cryptococcus neoformans.
    Nakamura Y; Kano R; Watanabe S; Hasegawa A
    J Clin Microbiol; 2000 Mar; 38(3):992-5. PubMed ID: 10698985
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Killing of Caenorhabditis elegans by Cryptococcus neoformans as a model of yeast pathogenesis.
    Mylonakis E; Ausubel FM; Perfect JR; Heitman J; Calderwood SB
    Proc Natl Acad Sci U S A; 2002 Nov; 99(24):15675-80. PubMed ID: 12438649
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cryptococcus neoformans CAP59 (or Cap59p) is involved in the extracellular trafficking of capsular glucuronoxylomannan.
    García-Rivera J; Chang YC; Kwon-Chung KJ; Casadevall A
    Eukaryot Cell; 2004 Apr; 3(2):385-92. PubMed ID: 15075268
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of laccase in the biology and virulence of Cryptococcus neoformans.
    Zhu X; Williamson PR
    FEMS Yeast Res; 2004 Oct; 5(1):1-10. PubMed ID: 15381117
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differentiation of Cryptococcus neoformans varieties and Cryptococcus gattii using CAP59-based loop-mediated isothermal DNA amplification.
    Lucas S; da Luz Martins M; Flores O; Meyer W; Spencer-Martins I; Inácio J
    Clin Microbiol Infect; 2010 Jun; 16(6):711-4. PubMed ID: 19694768
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Laccase and melanin in the pathogenesis of Cryptococcus neoformans.
    Williamson PR
    Front Biosci; 1997 Nov; 2():e99-107. PubMed ID: 9342305
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Cryptococcus neoformans cap10 and cap59 mutant strains, affected in glucuronoxylomannan synthesis, differentially activate human dendritic cells.
    Grijpstra J; Tefsen B; van Die I; de Cock H
    FEMS Immunol Med Microbiol; 2009 Nov; 57(2):142-50. PubMed ID: 19694810
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [CAP59 gene amplification in Cryptococcus neoformans and Cryptococcus gattii directly from a yeast suspension].
    Siachoque N; Jewtuchowicz VM; Iovannitti C; Mujica MT
    Rev Argent Microbiol; 2010; 42(2):91-4. PubMed ID: 20589327
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular identification of Cryptococcus neoformans serotypes.
    Enache-Angoulvant A; Chandenier J; Symoens F; Lacube P; Bolognini J; Douchet C; Poirot JL; Hennequin C
    J Clin Microbiol; 2007 Apr; 45(4):1261-5. PubMed ID: 17287323
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of capsule-associated genes of Cryptococcus neoformans.
    Okabayashi K; Kano R; Watanabe S; Hasegawa A
    Mycopathologia; 2005 Aug; 160(1):1-7. PubMed ID: 16160761
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.